0001764013-21-000045.txt : 20210323
0001764013-21-000045.hdr.sgml : 20210323
20210323085851
ACCESSION NUMBER: 0001764013-21-000045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210319
FILED AS OF DATE: 20210323
DATE AS OF CHANGE: 20210323
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MIGAUSKY GEORGE V
CENTRAL INDEX KEY: 0001134365
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38906
FILM NUMBER: 21763277
MAIL ADDRESS:
STREET 1: C/O DYAX CORP.
STREET 2: 300 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immunovant, Inc.
CENTRAL INDEX KEY: 0001764013
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832771572
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 917-580-3099
MAIL ADDRESS:
STREET 1: 320 WEST 37TH STREET
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Health Sciences Acquisitions Corp
DATE OF NAME CHANGE: 20190108
4
1
wf-form4_161650431840974.xml
FORM 4
X0306
4
2021-03-19
0
0001764013
Immunovant, Inc.
IMVT
0001134365
MIGAUSKY GEORGE V
320 W 37TH STREET, 6TH FLOOR
NEW YORK
NY
10018
1
0
0
0
Common Stock
2021-03-19
4
A
0
15500
0
A
60200
D
Stock Option (right to buy)
17.0
2021-03-19
4
A
0
23300
0
A
2031-03-19
Common Stock
23300.0
23300
D
Represents the number of shares underlying restricted stock unit awards ("RSUs") granted to the Reporting Person pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in their entirety one year after the date of grant on March 19, 2022, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
20,000 shares are the result of a pro rata distribution from Health Sciences Holdings, LLC, of which the Reporting Person was a member of Health Sciences Acquisition Corporation's board of directors.
The shares underlying the options vest one year after the date of grant on March 19, 2022, subject to the Reporting Person's continuous service to the Issuer as of such date.
/s/ Pamela Yanchik Connealy, attorney-in-fact for George V. Migausky
2021-03-23